The development prospection of HDAC inhibitors as a potential therapeutic direction in Alzheimer’s disease

Alzheimer’s disease (AD) is a chronic neurodegenerative disease, which is associated with learning and memory impairment in the elderly. Recent studies have found that treating AD in the way of chromatin remodeling via histone acetylation is a promising therapeutic regimen. In a number of recent stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Shuang-shuang, Zhang, Rui, Wang, Gang, Zhang, Yong-fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504819/
https://www.ncbi.nlm.nih.gov/pubmed/28702178
http://dx.doi.org/10.1186/s40035-017-0089-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504819/
https://www.ncbi.nlm.nih.gov/pubmed/28702178
http://dx.doi.org/10.1186/s40035-017-0089-1

Ejemplares similares